Related Experiment Video
Updated: Oct 12, 2026

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
The value of impurity. The second life of WEEE-derived yttrium in the pharmaceutical industry
Marinella Favot1, Roberta Curiazi2, Antonio Massarutto2
1Area Science Park, Padriciano 99, 34149 Trieste, Italy.
Abstract:
Among the strategic raw materials supporting today's digital and energy transition, rare earth elements (REE) pose increasing geopolitical and industrial-economic challenges. Urban mining offers a promising alternative, although the high energy costs associated with recycling remain a significant obstacle. This paper investigates the technical feasibility and economic viability of processes for obtaining secondary materials of lower purity. As an illustrative case study, we analysed the recovery of triflate-yttrium from a mixture of e-waste containing yttrium oxide at varying concentrations; the resulting material can be used in pharmaceutical applications. The study evaluates the economic efficiency and recycling effectiveness, achieving medium-to-high purities under economically viable conditions. These results demonstrate that the tested method can support circular processes in the e-waste chain at lower costs than market prices for high-purity raw material oxides used in the pharmaceutical sector, making the production of secondary raw materials preferable to the production of virgin raw materials derived from extraction processes with high environmental and social impact on the territories.
Related Concept Videos
Factors Affecting Solubility
Washing, Drying, and Ignition of Precipitates
Bioequivalence studies: Biowaivers
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Microbial Bioremediation of Uranium

